Author

Anaïs Merckx

InsermORCID 0000-0002-9756-7980Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:plant (other)· 1

Frequent Co-Authors

Emilie ZélieiD· 1 shared Jean‐François FranetichiD· 1 shared Lucille HervéiD· 1 shared Magali BlaudiD· 1 shared Mathilde Patat· 1 shared Murielle LoheziciD· 1 shared Nadia AmanzougagheneiD· 1 shared Quentin GOOR· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Emilie ZélieORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis derived fungal metabolite targeting Pyruvate Kinase II

Lucille Hervé, Nadia Amanzougaghene, Séverine Amand, Magali Blaud, Romain Coppée, Zaineb Fourati, Jean‐François Franetich, Quentin GOOR, Sandrine Houzé, Murielle Lohezic, Mathilde Patat, Véronique Sarrasin, Emilie Zélie, Valérie Soulard, Stéphane Mann, Anaïs Merckx

This study identifies skeletocutin E as a dual-stage antimalarial compound that inhibits Plasmodium falciparum pyruvate kinase II, showing efficacy against both blood and liver stages of the parasite.

bioRxiv · Mar 18, 2026 · PreprintMicrobiology